Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 6, 2006, Pages 852-872

  Dunning, Joel ^a   Treasure, Tom ^b   Versteegh, Michael ^c   Nashef, Samer A M ^d  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPIVACAINE; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; HEPARIN; IBUTILIDE; MAGNESIUM SULFATE; METOPROLOL; MORPHINE; POTASSIUM; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG FATALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EPIDURAL ANESTHESIA; GASTROINTESTINAL SYMPTOM; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; HYPOTENSION; INCIDENCE; LOBECTOMY; LUNG RESECTION; METHODOLOGY; MORBIDITY; OFF PUMP CORONARY SURGERY; PERICARDIOTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; SURGICAL TECHNIQUE; THORAX SURGERY; URINE RETENTION; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; EVIDENCE-BASED MEDICINE; HUMANS; MAGNESIUM; POSTOPERATIVE CARE; SOTALOL; THORACIC SURGICAL PROCEDURES;

EID: 33750937925     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.09.003     Document Type: Article

References (133)

1. Aranki S.F., Shaw D.P., Adams D.H., Rizzo R.J., Couper G.S., VanderVliet M., Collins Jr. J.J., Cohn L.H., and Burstin H.R. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94 (1996) 390-397 [see comment]
2. Creswell L.L., Schuessler R.B., Rosenbloom M., and Cox J.L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56 (1993) 539-549 [see comment]
3. Almassi G.H., Schowalter T., Nicolosi A.C., Aggarwal A., Moritz T.E., Henderson W.G., Tarazi R., Shroyer A.L., Sethi G.K., Grover F.L., and Hammermeister K.E. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg 226 (1997) 501-511
4. Mathew J.P., Parks R., Savino J.S., Friedman A.S., Koch C., Mangano D.T., Browner W.S., and Multicenter Study of Perioperative Ischemia Research Group. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. J Am Med Assoc 276 (1996) 300-306 [see comment]
5. Cook D.J., Guyatt G.H., Laupacis A., Sackett D.L., and Goldberg R.J. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 108 4, Suppl. (1995) 227S-230S
6. Dunning J., Prendergast B., and Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interactive Cardiovasc Thorac Surg (2003) 405-409
7. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation. J Am Coll Cardiol 2001;38:1266i-lxx.
8. Omorphos S., Hanif M., and Dunning J. Are prophylactic β-blockers of benefit in reducing the incidence of atrial fibrillation following coronary bypass surgery?. Interactive Cardiovasc Thorac Surg (2004) 641-646
9. Andrews T.C., Reimold S.C., Berlin J.A., and Antman E.M. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomised control trials. Circulation 84 (1991) III236-III244
10. Kowey P.R., Taylor J.E., Rials S.J., and Marinchak R.A. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 69 (1992) 963-965
11. Crystal E., Connolly S.J., Sleik K., Ginger T.J., and Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106 (2002) 75-80 [see comment]
12. Wurdeman R.L., Mooss A.N., Mohiuddin S.M., and Lenz T.L. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation /flutter after heart surgery: a meta-analysis. Chest 121 (2002) 1203-1210
13. Zimmer J., Pezzullo J., Choucair W., Southard J., Kokkinos P., Karasik P., Greenberg M.D., and Singh S.N. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 91 9 (2003) 1137-1140
14. Crystal E., Garfinkle M.S., Connolly S.S., Ginger T.T., Sleik K., and Yusuf S.S. Interventions for preventing postoperative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev (2004) 4
15. Ferguson Jr. T.B., Coombs L.P., and Peterson E.D. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Pre-operative B-blocker use and mortality and morbidity following CABG surgery in North America. J Am Med Assoc 287 (2002) 2221-2227
16. Eagle K.A., Guyton R.A., Davidoff R., Ewy G.A., Fonger J., Gardner T.J., Gott J.P., Herrmann H.C., Marlow R.A., Nugent W.C., O'Connor G.T., Orszulak T.A., Rieselbach R.E., Winters W.L., Yusuf S., Gibbons R.J., Alpert J.S., Eagle K.A., Garson Jr. A., Gregoratos G., Russell R.O., and Smith Jr. S.C. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). J Am Coll Cardiol 34 (1999) 1262-1347
17. Patel A., and Dunning J. Is Sotalol more effective than standard beta-blockers for prophylaxis of atrial fibrillation during cardiac surgery?. Interactive Cardiovasc Thorac Surg 4 (2005) 147-150
18. Suttorp M.J., Kingma J.H., Tijon Joe Gin R.M., van Hemel N.M., Koomen E.M., Defauw J.A., Adan A.J., and Ernst S.M. Efficacy and safety of low and high dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 100 (1990) 921-926
19. Suttorp M.J., Kingma J.H., Peels H.O., Koomen E.M., Tijssen J.G., van Hemel N.M., Defauw J.A., and Ernst S.M. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 68 (1991) 1163-1169
20. Auer J., Weber T., Berent R., Puschmann R., Hartl P., Ng C.K., Schwarz C., Lehner E., Strasser U., Lassnig E., Lamm G., and Eber B. Study of prevention of postoperative atrial fibrillation. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomised, placebo-controlled trial. Am Heart J 147 (2004) 636-643
21. Sanjuan R., Blasco M., Carbonell N., Jorda A., Nunez J., Martinez-Leon J., and Otero E. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg 77 (2004) 838-843
22. Janssen J., Loomans L., Harink J., Taams M., Brunninkhuis L., van der S.P., and Kootstra G. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomised open trial. Angiology 37 (1986) 601-609
23. Parikka H., Toivonen L., Heikkila L., Virtanen K., and Jarvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 31 (1998) 67-73
24. Nystrom U., Edvardsson N., Berggren H., Pizzarelli G.P., and Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac Cardiovasc Surg 41 (1993) 34-37
25. Abdulrahman O., Dale H.T., Levin V., Hallner M., Theman T., and Hassapyannes C. The comparative value of low dose sotalol vs metoprolol in the prevention of post-operative supraventricular arrythmais. Eur Heart J 20 Suppl (1999) 372
26. Dunning J., Botha P., and Amanullah M. Prophylactic amiodarone effectively prevents postoperative atrial fibrillation. Interactive Cardiovasc Thorac Surg (2004) 510-515
27. Daoud E.G., Strickberger S.A., Man K.C., Goyal R., Deeb G.M., Bolling S.F., Pagani F.D., Bitar C., Meissner M.D., and Morady F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791 [see comment]
28. Giri S., White C.M., Dunn A.B., Felton K., Freeman-Bosco L., Reddy P., Tsikouris J.P., Wilcox H.A., and Kluger J. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 357 (2001) 830-836 [see comment]
29. Kerstein J., Soodan A., Qamar M., Majid M., Lichstein E., Hollander G., and Shani J. Giving intravenous and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 126 (2004) 716-719
30. Butler J., Harriss D.R., Sinclair M., and Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. Br Heart J 70 (1993) 56-60
31. Hohnloser S.H., Meinertz T., Dammbacher T., Steiert K., Jahnchen E., Zehender M., Fraedrich G., and Just H. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 121 (1991) 89-95
32. Ronald A., and Dunning J. Bi-atrial pacing significantly reduces the incidence of atrial fibrillation post cardiac surgery. Interactive Cardiovasc Thorac Surg 4 (2005) 33-40
33. Rostron A., Sanni A., and Dunning J. Does magnesium prophylaxis reduce the incidence of atrial fibrillation following coronary bypass surgery?. Interactive Cardiovasc Thorac Surg 4 (2005) 52-58
34. Miller S., Crystal E., Garfinkle M., Lau C., Lashevsky I., and Connolly S.J. Effects of Magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 91 (2005) 618-623
35. Alghamdi A.A., Al-Radi O.O., and Latter D.A. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis. J Card Surg 20 (2005) 293-299
36. Shiga T., Wajima Z., Inoue T., and Ogawa R. Magnesium prophylaxis for arrhythmia after cardiac surgery: a meta-analysis of randomised controlled trials. Am J Med 117 (2004) 325-333
37. Toraman F., Karabulut E.H., Alhan H.C., Dagdelen S., and Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 72 (2001) 1256-1261
38. Forlani S., De Paulis R., de Notaris S., Nardi P., Tomai F., Proietti I., Ghini A.S., and Chiariello L. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 74 (2002) 720-725
39. Hazelrigg S.R., Boley T.M., Cetindag I.B., Moulton K.P., Trammell G.L., Polancic J.E., Shawgo T.S., Quin J.A., and Verhulst S. The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 77 (2004) 824-830
40. Yeatman M., Caputo M., Narayan P., Lotto A.A., Ascione R., Bryan A.J., and Angelini G.D. Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 73 (2002) 112-118
41. Bert A.A., Reinert S.E., and Singh A.K. A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 15 (2001) 204-209
42. Kaplan M., Kut M.S., Icer U.A., and Demirtas M.M. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 125 (2003) 344-352
43. Shrivastava V., Nyawo B., Dunning J., and Morritt G. Is there a role for prophylaxis against atrial fibrillation for patients undergoing lung surgery?. Interactive Cardiovasc Thorac Surg (2004) 656-662
44. Amar D., Roistacher N., Burt M.E., Rusch V.W., Bains M.S., Leung D.H., Downey R.J., and Ginsberg R.J. Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg 63 (1997) 1374-1381
45. Van Mieghem W., Tits G., Demuynck K., Lacquet L., Deneffe G., Tjandra-Maga T., and Demedts M. Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann Thorac Surg 61 (1996) 1083-1085
46. Van Mieghem W., Coolen L., Malysse I., Lacquet L.M., Deneffe G.J., and Demedts M.G. Amiodarone and the development of ARDS after lung surgery. Chest 105 (1994) 1642-1645 [see comment]
47. Borgeat A., Biollaz J., Bayer-Berger M., Kappenberger L., Chapuis G., and Chiolero R. Prevention of arrhythmias by flecainide after non-cardiac thoracic surgery. Ann Thorac Surg 48 (1989) 232-234
48. Borgeat A., Petropoulos P., Cavin R., Biollaz J., Munafo A., and Schwander D. Prevention of arrhythmias after non cardiac thoracic operations: flecainide versus digoxin. Ann Thorac Surg 51 (1991) 964-967
49. Jakobsen C.J., Bille S., Ahlburg P., Rybro L., Hjortholm K., and Andresen E.B. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 11 (1997) 746-751
50. Bayliff C.D., Massel D.R., Inculet R.I., Malthaner R.A., Quinton S.D., Powell F.S., and Kennedy R.S. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 67 (1999) 182-186
51. Oka T., Ozawa Y., and Ohkubo Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth Analg 93 (2001) 253-259 [see comment]
52. Terzi A., Furlan G., Chiavacci P., Dal Corso B., Luzzani A., and Dalla V.S. Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate. Cardiovasc Surg 44 (1996) 300-303 [see comment]
53. Raja S.G., Behranwala A.A., and Dunning J. Does off-pump coronary artery surgery reduce the incidence of postoperative atrial fibrillation?. Interactive Cardiovasc Thorac Surg (2004) 647-652
54. Reston J.T., Tregear S.J., and Turkelson C.M. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 1510-1515 [review]
55. Reston J.T., Tregear S.J., and Turkelson C.M. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 1510-1515
56. Van der Heijden G.J.M.G., Nathoe H.M., Jansen E.W.L., and Grobbee D.E. Meta-analysis on the effect of off-pump coronary bypass surgery. Eur J Cardiothorac Surg 26 (2004) 81-84
57. van Dijk D., Jansen E.W., Hijman R., Nierich A.P., Diephuis J.C., Moons K.G., Lahpor J.R., Borst C., Keizer A.M., Nathoe H.M., Grobbee D.E., de Jaegere P.P., Kalkman C.J., and Octopus Study Group. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomised trial. J Am Med Assoc 287 (2002) 1405-1412 [see comment]
58. Puskas J.D., Williams W.H., Duke P.G., Staples J.R., Glas K.E., Marshall J.J., Leimbach M., Huber P., Garas S., Sammons B.H., McCall S.A., Petersen R.J., Bailey D.E., Chu H., Mahoney E.M., Weintraub W.S., and Guyton R.A. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomised comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 797-808 [see comment]
59. Lee J.D., Lee S.J., Tsushima W.T., Yamauchi H., Lau W.T., Popper J., Stein A., Johnson D., Lee D., Petrovitch H., and Dang C.R. Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomised trial. Ann Thorac Surg 76 (2003) 18-25
60. Angelini G.D., Taylor F.C., Reeves B.C., and Ascione R. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 359 (2002) 1194-1199 [see comment]
61. Straka Z., Widimsky P., Jirasek K., Stros P., Votava J., Vanek T., Brucek P., Kolesar M., and Spacek R. Off-pump versus on-pump coronary surgery: final results from a prospective randomised study PRAGUE-4. Ann Thorac Surg 77 (2004) 789-793
62. van Dijk D., Nierich A.P., Jansen E.W., Nathoe H.M., Suyker W.J., Diephuis J.C., van Boven W.J., Borst C., Buskens E., Grobbee D.E., Robles De Medina E.O., de Jaegere P.P., and Octopus Study Group. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomised study. Circulation 104 (2001) 1761-1766
63. Muneretto C., Bisleri G., Negri A., Manfredi J., Metra M., Nodari S., and Dei C.L. Off-pump coronary artery bypass surgery technique for total arterial myocardial revascularization: a prospective randomised study. Ann Thorac Surg 76 (2003) 778-782
64. Gerola L.R., Buffolo E., Jasbik W., Botelho B., Bosco J., Brasil L.A., and Branco J.N. Off-pump versus on-pump myocardial revascularization in low-risk patients with one or two vessel disease: perioperative results in a multicenter randomised controlled trial. Ann Thorac Surg 77 (2004) 569-573
65. Farsak B., Gunaydin S., Tokmakoglu H., Kandemir O., Yorgancioglu C., and Zorlutuna Y. Posterior pericardiotomy reduces the incidence of supra-ventricular arrhythmias and pericardial effusion after coronary artery bypass grafting. Eur J Cardiothorac Surg 22 (2002) 278-281
66. Alex J., and Guvendik L. Evaluation of ventral cardiac denervation as a prophylaxis against AF after coronary artery bypass grafting. Ann Thorac Surg 79 (2005) 517-520
67. Davis Z., and Jacobs H.K. Aortic fat pad destruction and post operative AF. Card Electrophysiol Rev 7 (2003) 185-188
68. Melo J., Voigt P., Sonmez B., Ferreira M., Abecasis M., Rebocho M., Timoteo A., Aguiar C., Tansal S., Arbatli H., and Dion R. Ventral cardiac denervation reduces the incidence of AF after coronary artery bypass grafting. J Thorac Cardiovasc Surg 127 (2004) 511-516 [see comment]
69. Dunning J., Khasati N., and Prendergast B. What is the optimal medical treatment for stable cardiac surgical patients who go into atrial fibrillation after their operation?. Interactive Cardiovasc Thorac Surg (2004) 46-51
70. Gavaghan T.P., Feneley M.P., Campbell T.J., and Morgan J.J. Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy. ANZ J Med 15 (1985) 27-32
71. Colquhoun I.W., Berg G.A., el Fiky M., Hurle A., Fell G.S., and Wheatley D.J. Arrhythmia prophylaxis after coronary artery surgery. A randomised controlled trial of intravenous magnesium chloride. Eur J Cardiothorac Surg 7 (1993) 520-523
72. Mooe T., Gullsby S., Rabben T., and Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 7 (1996) 475-478
73. Glikson M., Espinosa R.E., and Hayes D.L. Expanding indications for permanent pacemakers. Ann Intern Med 123 (1995) 443-451 [review]
74. Jacquet L., Evenepoel M., Marenne F., Evrard P., Verhelst R., Dion R., and Goenen M. Haemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 8 (1994) 431-436
75. Cochrane A.D., Siddins M., Rosenfeldt F.L., Salamonsen R., McConaghy L., Marasco S., and Davis B.B. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. Eur J Cardiothorac Surg 8 (1994) 194-198
76. Di Biasi P., Scrofani R., Paje A., Cappiello E., Mangini A., and Santoli C. Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg 9 (1995) 587-591 [see comment]
77. Karthik S., Musleh G., Grayson A.D., Keenan D.J., Pullan D.M., Dihmis W.C., Hasan R., and Fabri B.M. Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass. Ann Thorac Surg 77 (2004) 1245-1249
78. Orszulak T.A., Schaff H.V., Pluth J.R., Danielson G.K., Puga F.J., Ilstrup D.M., and Anderson B.J. The risk of stroke in the early postoperative period following mitral valve replacement. Eur J Cardiothorac Surg 9 (1995) 615-619
79. Groh M.A., Sutherland S.E., Burton III H.G., Johnson A.M., and Ely S.W. Port-access coronary artery bypass grafting: technique and comparative results. Ann Thorac Surg 68 (1999) 1506-1508
80. Campbell T.J., Gavaghan T.P., and Morgan J.J. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. Br Heart J 54 (1985) 86-90
81. Janssen J., Loomans L., Harink J., Taams M., Brunninkhuis L., van der S.P., and Kootstra G. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomised open trial. Angiology 37 (1986) 601-609
82. Jideus L., Ericson M., Stridsberg M., Nilsson L., Blomstrom P., and Blomstrom-Lundqvist C. Diminished circadian variation in heart rate variability before surgery in patients developing postoperative AF. Scand Cardiovasc J 35 (2001) 238-244
83. Crombie I.G. The pocket guide to critical appraisal (1996), BMJ Publishing group, London
84. Zaman A.G., Archbold R.A., Helft G., Paul E.A., Curzen N.P., and Mills P.G. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 101 (2000) 1403-1408 [see comment]
85. King K.B., Clark P.C., and Hicks Jr. G.L. Patterns of referral and recovery in women and men undergoing coronary artery bypass grafting. Am J Cardiol 69 (1992) 179-182
86. Seguin P., Signouret T., Laviolle B., Branger B., and Malledant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 32 (2004) 722-726 [see comment]
87. Kilger E., Weis F.C., Goetz A.E., Frey L., Kesel K., Schutz A., Lamm P., Uberfuhr P., Knoll A., Felbinger T.W., and Peter K. Intensive care after minimally invasive and conventional coronary surgery: a prospective comparison. Intensive Care Med 27 (2001) 534-539 [see comment]
88. Wistbacka J.O., Koistinen J., Karlqvist K.E., Lepojarvi M.V., Hanhela R., Laurila J., Nissinen J., Pokela R., Salmela E., and Ruokonen A. Magnesium substitution in elective coronary artery surgery: a double-blind clinical study. J Cardiothorac Vasc Anesth 9 (1995) 140-146
89. Dunning J., Nagarajan D.V., Amanullah M., and Nouraei S.M. What is the optimal anticoagulation management of patients post-cardiac surgery who go into atrial fibrillation?. Interactive Cardiovasc Thorac Surg (2004) 503-509
90. Hart R.G., Benavente O., McBride R., and Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131 (1999) 492-501
91. Hylek E.M., Go A.S., Yuchiao C., Jensvold N.G., Henault L.E., Selby J.V., and Singer D.E. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 (2003) 1019-1026
92. Villareal R.P., Hariharan R., Liu B.C., Kar B., Lee V., Elayda M., Lopez A., Rasekh A., Wilson J.M., and Massumi A. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 43 (2004) 742-748
93. Stamou S.C., Hill P.C., Dangas G., Pfister A.J., Boyce S.W., Dullum M.K., Bafi A.S., and Corso P. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 32 (2001) 1508-1513
94. Malouf J.F., Alam S., Gharzeddine W., and Stefadouros MA. The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery. Eur Heart J 14 (1993) 1451-1457 [erratum in Eur Heart J 1994 Apr;15(4):583-4]
95. Daoud E.G. Management of atrial fibrillation in the post-cardiac surgery setting. Cardiol Clin 22 (2004) 159-166 [review, 69 refs.]
96. Nagarajan D.V., and Dunning J. Is antero-posterior position superior to antero-lateral position for placement of electrodes for external cardioversion of atrial fibrillation?. Interactive Cardiovasc Thorac Surg (2004) 386-389
97. Patel A., Rao J., and Dunning J. Does magnesium offer any additional benefit in patients having anti-arrhythmic treatment for atrial fibrillation following cardiac surgery?. Interactive Cardiovasc Thorac Surg 4 (2005) 193-196
98. Kalus J.S., Spencer A.P., and Tsikouris J.P. Impact of prophylactic iv magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health-Syst Pharm 60 (2003) 2308-2312
99. Brodsky M.A., Orlov M.V., Capparelli E.V., Allen B.J., Iseri L.T., Ginkel M., and Orlov Y.S..K. Magnesium therapy in new onset atrial fibrillation. Am J Cardiol 73 (1994) 1227-1229
100. Hays J.V., Gilman J.K., and Rubal B.J. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation. Ann Emerg Med 24 (1994) 61-64
101. Frick M., Ostergren J., and Rosenqvist M. Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation. Am J Cardiol 84 (1999) 104-108
102. Chiladakis J.A., Stathopoulos C., Davlouros P., and Manolis A.S. Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol 79 (2001) 287-291
103. Moran J.L., Gallagher J., Peake S.L., Cunningham D.N., Salagaras M., and Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomised study. Crit Care Med 23 11 (1995) 1816-1824
104. Gullestad L., Birkeland K., Molstad P., Hoyer M.M., and Vanberg P. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol 16 (1993) 429-434
105. Thompson A.E., Hirsch G.M., and Pearson G.J. Assessment of new onset post coronary artery bypass surgery atrial fibrillation: current practice pattern review and the development of treatment guidelines. J Clin Pharm Ther 27 (2002) 21-37
106. Olshansky B. Management of atrial fibrillation after coronary artery bypass graft. Am J Cardiol 78 8A (1996) 27-34 [review, 57 refs.]
107. Daoud E.G. Management of atrial fibrillation in the post-cardiac surgery setting. Cardiol Clin 22 1 (2004) 159-166 [review, 69 refs.]
108. Prystowsky E.N. Management of atrial fibrillation: therapeutic options and clinical decisions. Am J Cardiol 85 (2000) 3D-11D [review, 51 refs.]
109. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073 [review, 104 refs.]
110. Hogue Jr. C.W., and Hyder M.L. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 69 (2000) 300-306 [review, 94 refs.]
111. Creswell L.L., and Damiano Jr. R.J. Postoperative atrial fibrillation: an old problem crying out for new solutions. J Thorac Cardiovasc Surg 121 (2001) 638-641
112. Jayam V.K.S., Flaker G.C., and Jones J.W. Atrial fibrillation after coronary bypass: aetiology and pharmacologic prevention. Cardiovasc Surg 10 (2002) 351-358
113. Hill L.L., De Wet C., and Hogue Jr. C.W. Management of atrial fibrillation after cardiac surgery. Part II. Prevention and treatment. J Cardiothorac Vasc Anesth 16 (2002) 626-637
114. Bharucha D.B., and Kowey P.R. Management and prevention of atrial fibrillation after cardiovascular surgery. Am J Cardiol 85 (2000) 20D-24D [review, 45 refs.]
115. Reiffel J.A. Drug choices in the treatment of atrial fibrillation. Am J Cardiol 85 10A (2000) 12D-19D [review, 62 refs.]
116. Pires L.A., Wagshal A.B., Lancey R., and Huang S.K. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J 129 (1995) 799-808 [review, 50 refs.]
117. The National Collaborating Centre for Chronic Conditions for the National Institute for Health and Clinical Excellence. The management of atrial fibrillation. NICE, London; 2006.
118. Hjelms E. Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg 26 (1992) 193-196
119. Wafa S.S., Ward D.E., Parker D.J., and Camm A.J. Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting. Am J Cardiol 63 (1989) 1058-1064
120. Soucier R., Silverman D., Abordo M., Jaagosild P., Abiose A., Madhusoodanan K.P., Therrien M., Lippman N., Dalamagas H., and Berns E. Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared with rate control alone (the PIPAF study). Med Sci Monit 9 (2003) I19-I23
121. Bernard E.O., Schmid E.R., Schmidlin D., Scharf C., Candinas R., and Germann R. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomised study. Crit Care Med 31 4 (2003) 1031-1034
122. Mooss A.N., Wurdeman R.L., Mohiuddin S.M., Reyes A.P., Sugimoto J.T., Scott W., Hilleman D.E., and Seyedroudbari A. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery. Am Heart J 140 (2000) 176-180
123. Geelen P., O'Hara G.E., Roy N., Talajic M., Roy D., Plante S., and Turgeon J. Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. Am J Cardiol 84 (1999) 345-347
124. Tisdale J.E., Padhi I.D., Goldberg A.D., Silverman N.A., Webb C.R., Higgins R.S., Paone G., Frank D.M., and Borzak S. A randomised, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 135 (1998) 739-747
125. Frost L., Mortensen P.E., Tingleff J., Platou E.S., Christiansen E.H., Christiansen N., and Dofetilide Post-CABG Study Group. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Int J Cardiol 58 (1997) 135-140
126. McAlister H.F., Luke R.A., Whitlock R.M., and Smith W.M. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. J Thorac Cardiovasc Surg 99 (1990) 911-918 [see comment]
127. Connolly S.J., Mulji A.S., Hoffert D.L., Davis C., and Shragge B.W. Randomised placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery. J Am Coll Cardiol 10 (1987) 1145-1148
128. Larbuisson R., Venneman I., and Stiels B. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothorac Vasc Anesth 10 (1996) 229-234
129. Salerno D.M., Dias V.C., Kleiger R.E., Tschida V.H., Sung R.J., Sami M., Giorgi L.V., and The Diltiazem-AF/Flutter Study Group. Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. Am J Cardiol 63 15 (1989) 1046-1051
130. Lee J.K., Klein G.J., Krahn A.D., Yee R., Zarnke K., Simpson C., and Skanes A. Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. Card Electrophysiol Rev 7 (2003) 178-184
131. Lee J.K., Klein G.J., Krahn A.D., Yee R., Zarnke K., Simpson C., Skanes A., and Spindler B. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomised pilot study. Am Heart J 140 (2000) 871-877
132. Hilleman D.E., Reyes A.P., Mooss A.N., and Packard K.A. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin 19 (2003) 376-382
133. VanderLugt J.T., Mattioni T., Denker S., Torchiana D., Ahern T., Wakefield L.K., Perry K.T., and Kowey P.R. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 100 (1999) 369-375